Tfcp2l1-KO 基因敲除小鼠

1. Nassar, Amin H, Abou Alaiwi, Sarah, Baca, Sylvan C, Kwiatkowski, David J, Freedman, Matthew L. 2023. Epigenomic charting and functional annotation of risk loci in renal cell carcinoma. In Nature communications, 14, 346. doi:10.1038/s41467-023-35833-5. https://pubmed.ncbi.nlm.nih.gov/36681680/

2. Otero-Albiol, D, Santos-Pereira, J M, Lucena-Cacace, A, Yoshida, Y, Carnero, A. 2024. Hypoxia-induced immortalization of primary cells depends on Tfcp2L1 expression. In Cell death & disease, 15, 177. doi:10.1038/s41419-024-06567-z. https://pubmed.ncbi.nlm.nih.gov/38418821/

3. Wang, Xiaohu, Wang, Xiaoxiao, Zhang, Shuyuan, Zhang, Xuewu, Ye, Shou-Dong. 2019. The transcription factor TFCP2L1 induces expression of distinct target genes and promotes self-renewal of mouse and human embryonic stem cells. In The Journal of biological chemistry, 294, 6007-6016. doi:10.1074/jbc.RA118.006341. https://pubmed.ncbi.nlm.nih.gov/30782842/

4. Zhang, Yan, Ding, Huiwen, Wang, Xiaoxiao, Gan, Ruoyi, Ye, Shou-Dong. . MK2 promotes Tfcp2l1 degradation via β-TrCP ubiquitin ligase to regulate mouse embryonic stem cell self-renewal. In Cell reports, 37, 109949. doi:10.1016/j.celrep.2021.109949. https://pubmed.ncbi.nlm.nih.gov/34731635/

5. Zeng, C, Zhang, Y, Lin, C, Li, Y, Guan, H. 2024. TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression. In Journal of endocrinological investigation, 47, 2953-2968. doi:10.1007/s40618-024-02392-5. https://pubmed.ncbi.nlm.nih.gov/38753296/